The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based settings for patients at risk for chlamydia, gonorrhea, and Mycoplasma ...
Metropolis Healthcare has collaborated with Roche Diagnostics India to introduce ... cancer screening accessible across India. Our cobas HPV DNA test provides women with a solution that allows ...
Roche, the parent company of Indianapolis-based Roche Diagnostics, said it received FDA clearance to sell a new test to help determine a patient’s risk of an often untested but common ...
“The expanded menu is part of a test Krispy Kreme is implementing in select U.S. markets,” according to a Krispy Kreme news release. “The menu includes returning popular doughnuts that were ...
Roche Holding said the U.S. Food and Drug Administration approved a test to identify patients with a specific type of breast cancer. The Swiss pharmaceutical company said the FDA backed a label ...
Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S.
The Baxter Street Newk’s has recently introduced four new items to its menu: the Spicy Chicken Bacon Wrap, the Spicy Jalapeño Ranch Salad, the Newk’s “Q” Pizza and The Italian sub sandwich.
Thursday, Orange County students got a chance to decide what’s on the breakfast menu next year. The school district invited 150 students to a taste test this morning to try 24 options ...
SpaceX’s Starship rocket exploded just minutes into its seventh test flight, an unexpected setback after the Elon Musk-led company had made steady progress advancing the vehicle’s capabilities.
Roche and Eli Lilly have started testing a blood test that could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up the ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).